David DEVOS

David Devos is a distinguished Professor of Medicine at Université de Lille, with a focus on Medical Pharmacology and Neurology. His academic career began in September 2000, and David has concurrently served as a university researcher at Inserm since 2015. A graduate with Doctorate degrees in Neurology and Neuroscience from the University of Lille, David Devos has also been a hospital physician at the Centre Hospitalier Universitaire of Lille from 2002 to 2010. In addition to academic roles, David Devos is the Chief Scientific Officer at InBrain Pharma, a biotechnology startup specializing in innovative treatments for neurodegenerative diseases, leveraging promising research outcomes from the University’s laboratory U1171.